Fresenius Medical Care AG (FMS) · Company profile · Eqvero

Fresenius Medical Care AG

FMSNYSE

Unit: EUR	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	19.63 bn EUR	19.34 bn EUR	19.45 bn EUR	19.4 bn EUR	17.62 bn EUR
Cost of revenue	14.6 bn EUR	14.58 bn EUR	14.53 bn EUR	14.5 bn EUR	12.85 bn EUR
Gross profit	—	—	—	5.31 bn EUR	5.08 bn EUR
Research and development expense	157.98 m EUR	183.49 m EUR	231.97 m EUR	228.62 m EUR	220.78 m EUR
Selling, general and administrative expense	3.03 bn EUR	3.14 bn EUR	3.2 bn EUR	3.17 bn EUR	2.77 bn EUR
Operating profit	1.83 bn EUR	1.39 bn EUR	1.37 bn EUR	1.51 bn EUR	1.85 bn EUR
Interest expense	375.22 m EUR	393.32 m EUR	420.9 m EUR	359 m EUR	343.81 m EUR
Profit before tax	1.51 bn EUR	1.06 bn EUR	1.03 bn EUR	1.22 bn EUR	1.57 bn EUR
Income tax expense	320.97 m EUR	316.06 m EUR	300.56 m EUR	324.95 m EUR	352.83 m EUR
Net income (reported basis)	1.19 bn EUR	740.87 m EUR	732.46 m EUR	894.33 m EUR	1.22 bn EUR
Net income attributable to owners of the parent	978.37 m EUR	537.91 m EUR	499 m EUR	673.41 m EUR	969.31 m EUR
Basic earnings per share	3.36 EUR/share	1.83 EUR/share	1.7 EUR/share	2.3 EUR/share	3.31 EUR/share
Diluted earnings per share	3.36 EUR/share	1.83 EUR/share	1.7 EUR/share	2.3 EUR/share	3.31 EUR/share

Quotes are end-of-day data. Content is for research purposes and is not investment advice.